Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis

BACKGROUND: Patients with cancer are considered a priority group for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of contracting severe Coronavirus Disease 2019 (COVID-19). However, limited data exist regarding the efficacy of immunisation in this po...

Descripción completa

Detalles Bibliográficos
Autores principales: Becerril-Gaitan, Andrea, Vaca-Cartagena, Bryan F., Ferrigno, Ana S., Mesa-Chavez, Fernanda, Barrientos-Gutiérrez, Tonatiuh, Tagliamento, Marco, Lambertini, Matteo, Villarreal-Garza, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548030/
https://www.ncbi.nlm.nih.gov/pubmed/34794855
http://dx.doi.org/10.1016/j.ejca.2021.10.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548030/
https://www.ncbi.nlm.nih.gov/pubmed/34794855
http://dx.doi.org/10.1016/j.ejca.2021.10.014

Ejemplares similares